Another Top Ten Global Pharmaceutical and Medical Device Leader Selects Model N Revenue Management Suite

Share Article

Win reflects Model N's position as the preferred revenue management partner for global life science leaders.

As the industry moves forward with new strategies to address increasing globalization, intense price pressures, and changing regulatory requirements, Life Science innovators are upgrading the systems and processes that manage the end-to-end revenue life cycle, including regulatory compliance.

Model N, Inc., the leader in Revenue Management solutions, today announced that another global top ten pharmaceutical and medical device manufacturer has selected Model N's full Pharmaceutical and Medical Technology Commercial Revenue Management Suites. By selecting Model N, the manufacturer will align its business-critical pricing, contracting, and settlements processes across both its U.S. and international businesses.

After an extensive evaluation by the customer of competitive solutions, including incumbent contracting and ERP solutions, the manufacturer decided Model N was best suited to handle its growing commercial business requirements and to complement its legacy SAP ERP implementation.

Key Selection Factors

  •     Model N is the only vendor that possesses the experience, technology, and domain expertise required to meet the unique business needs of both the pharmaceutical and medical technology industries
  •     Model N's integrated Revenue Management Suite, proven in production with major Life Science companies, offers a dramatic advantage over risky, first-generation competitive solutions
  •     The comprehensive capabilities of Model N's fifth-generation platform meet the majority of the manufacturer's needs out of the box and deliver significant usability advantages
  •     Model N's expertise and experience integrating with SAP and other legacy /incumbent systems demonstrated that the project would leverage and complement existing investments

Supporting Quote
"As the industry moves forward with new strategies to address increasing globalization, intense price pressures, and changing regulatory requirements, Life Science innovators are upgrading the systems and processes that manage the end-to-end revenue life cycle, including regulatory compliance." said Sujay Jadhav, General Manager, Life Sciences, at Model N. "As our recent spate of top ten wins has shown, industry leaders are turning to Model N's fifth-generation Revenue Management platform to gain competitive and financial advantage. Our investment in product innovation, continued growth and stability, and increasing global reach are proving to be invaluable to Life Science leaders and we are pleased to welcome another top ten Life Science customer to the Model N community."

Resources
Case Study: Pharma Leader Achieves Significant ROI with Revenue Management
AMR Research Report: How to Grow Revenue and Margins in a Downturn

About Model N
Model N is a leader in Revenue Management solutions, offering an integrated suite of applications for analytics, pricing strategy and execution, contracts, compliance, and settlements optimized for the industry practices of Life Sciences and High Tech companies.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Cassidy
Visit website